ScholarWorks@Korea University College of Medicine: Choi, Cheol Ung

Detailed Information

Choi, Cheol Ung (최철웅)

Guro Hospital (Department of Cardiology, Guro Hospital)

Research Area: 급성 관상동맥 증후군, 동맥경화, 고혈압, Acute coronary syndrome, Atherosclerosis, Hypertension

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:15||Percutaneous coronary intervention:12||Coronary artery spasm:10||drugeluting stent:10||Drugeluting stent:9||coronary artery disease:9||atrial fibrillation:8||Atrial fibrillation:8||chronic total occlusion:7||coronary artery spasm:7||Acute myocardial infarction:7||Acetylcholine:7||acute myocardial infarction:7||Diabetes mellitus:6||acetylcholine:6||catheter ablation:5||diabetes mellitus:5||Clinical outcomes:5||Peripheral artery disease:5||Platelet function:4||outcomes:4||computed tomography:4||Angioplasty:4||Percutaneous transluminal angioplasty:4||Coronary artery disease:4||hypertension:4||Myocardial infarction:4||Sirolimuseluting stents:3||left atrium:3||Hypertension:3||stroke:3||critical limb ischemia:3||Angiotensin converting enzyme inhibitor:3||coronary angiography:3||nonSTsegment elevation myocardial infarction:3||pulse wave velocity:3||cardiovascular disease:3||Drugeluting stents:3||myocardial infarction:3||Heart failure:3||Creactive protein:3||Chronic total occlusion:3||lipoprotein(a):3||angina:3||Zotarolimus:3||endothelial dysfunction:3||Acetylcholine provocation test:3||risk factors:2||coronary vasospasm:2||diabetes:2||Echocardiography:2||diastolic function:2||angiotensin receptor blocker:2||Paclitaxeleluting stents:2||Aspirin:2||South Korea:2||AMI:2||prehospital delay:2||Hyperuricemia:2||Statins:2||radial artery:2||Iliac artery:2||Atorvastatin:2||Prevalence:2||Primary clinics:2||blood pressure:2||Endovascular therapy:2||Myocardial bridge:2||restenosis:2||revascularization:2||Type 2 diabetes:2||Uric acid:2||Catheter ablation:2||cardiorespiratory fitness:2||Chest pain:2||Resistant hypertension:2||DES:2||Vasospastic angina:2||VerifyNow:2||statin:2||Calcium channel blocker:2||Left atrium:2||clinical outcomes:2||acute coronary syndrome:2||medical therapy:2||treatment outcome:2||uric acid:2||vasospasm:2||multivessel disease:2||coronary heart disease:2||nonSTelevation myocardial infarction:2||Drug eluting stents:2||Depression:1||Diabetes:1||Diastolic dysfunction:1||Diltiazem:1||Drug eluting stent:1||Edema index:1||Effectiveness:1||Electric countershock:1||Electrocardiogram:1||Endothelial function:1||Endothelium:1||Enoxaparin:1||Everolimus:1||Everolimuseluting stents:1||Exercise Capacity:1||Fibrinolysis:1||Fistula:1||Fixeddose combination:1||Flow mediated dilation:1||Framingham risk score:1||Function:1||Gastroesophageal reflux:1||Glucose lowering agent:1||Graft stent:1||HMGB1:1||Haematopoietic activity:1||Heart atria:1||Heart atria/abnormalities:1||Hemoglobin A1c:1||Histomorphometry:1||Hypertrophy:1||IL17:1||Imaging:1||Insignificant stenosis:1||Insulin resistance:1||Intravascular ultrasound:1||Ischemic event:1||Ischemic heart disease:1||Korean:1||L1 SMI:1||Lacidipine:1||Large coronary artery:1||Left atrial function:1||Left main coronary artery:1||Linear ablation:1||Long coronary lesion:1||Longterm clinical outcome:1||Lung fluid content:1||MACE:1||MDCT:1||MINOCA:1||Major adverse cardiac event:1||Major adverse cardiac events:1||Major clinical outcomes:1||Masked hypertension:1||Mean platelet volume:1||Medication therapy:1||Metabolic equivalent:1||Metal jacket:1||Microfluidic:1||Morning hypertension:1||Mortality:1||Multivessel disease:1||Myocardial injury:1||NSTEMI:1||Neointima:1||Network meta analysis:1||Neutrophil/lymphocyte ratio:1||New onset diabetes mellitus:1||Newonset diabetes mellitus:1||Nitinol:1||Nomogram:1||NonST Elevated Myocardial Infarction:1||Noncardiac surgery:1||OCT:1||Occulusion:1||Older people:1||Outcomes:1||Oxygen consumption:1||P2Y12:1||PET/CT:1||PFA200:1||PTA:1||Percataneous coronary:1||Percutaneous Coronary Intervention:1||Percutaneous transluminal coronary angioplasty:1||Peripheral arterial disease:1||Peripheral vascular disease:1||Polymer:1||Posterior wall:1||Preserved LV systolic function:1||Prognosis:1||Propafenone.:1||Psychiatric status rating scales:1||Pulse wave velocity:1||RAS inhibitor:1||ROC curve:1||Reninangiotensin system inhibitors:1||Republic of Korea:1||Restenosis:1||Risk factors:1||Rosuvastatin:1||SCAD:1||SES:1||ST elevation myocardial infarction:1||ST segment elevation myocardial infarction:1||STelevation myocardial infarction:1||STsegment elevation myocardial infarction:1||STsegment myocardial infarction:1||Secondary prevention:1||Self expandable metallic stent:1||Selfexpanding nitinol stents:1||Sex:1||Sex Factors:1||Shear rates:1||Single coronary artery:1||Sleep deprivation:1||Sleep disorders:1||Sleep quality:1||Spot stenting:1||Statin:1||Stent:1||Stent oversizing:1||StentBoost:1||Superficial femoral artery:1||Systolic dysfunction:1||Thromboelastography:1||Transcatheter aortic valve implantation:1||Transesophageal incidental findings:1||Transfemoral intervention:1||Transluminal:1||Transradial intervention:1||Unfractionated heparin:1||Validation study:1||Valsartan:1||Vascular complications:1||Vascular endothelium:1||Vascular patency:1||Vasoconstriction:1||Vasomotion type:1||ZES:1||Zotarolimuseluting stents:1||aPWV:1||abdominal:1||adjunctive balloon:1||aging:1||air pollution:1||allcause death:1||amputation:1||anaemia:1||angiography:1||angiotensin converting enzyme inhibitor:1||antihypertensive:1||antiplatelet:1||antithrombotic agent:1||antithrombotic therapy:1||anysis200 analyzer:1||aorta:1||aortic stiffness:1||arterial grafts:1||arterial inflammation:1||arterial pulse wave velocity:1||arterial stiffness:1||arteriosclerosis/blood:1||aspirin:1||atrial function:1||atrial function, left/physiology:1||augmentation index:1||bilateral coronary artery fistula:1||biological markers/blood:1||bisoprolol:1||blood pressure control:1||blood sugar control:1||body composition:1||body mass index:1||cardiac rehabilitation:1||cardiac volume:1||cardiomyopathies:1||cardiovascular:1||cardiovascular death:1||cardiovascular events:1||carotid intimamedia thickness:1||carvedilol:1||celecoxib:1||central blood pressure:1||cerebral infarction:1||cholesterol, LDL/analysis/blood/classification/drug effects:1||chronic kidney disease:1||clinical events:1||clinical followup:1||clinical outcome:1||collateral circulation:1||communication between two fistulas:1||computed tomography angiography:1||coronary:1||coronary artery disease/prevention & control/therapy:1||coronary artery dissection:1||coronary microvascular function:1||coronary spasm:1||cytokines:1||dense lowdensity lipoprotein:1||diabetic:1||diastolic blood pressure:1||direct intraarterial measurement:1||disease progression:1||dissection:1||drug eluting stent:1||drugeluting stents:1||dual drugeluting stent:1||dyslipidemia:1||eczema:1||elderly:1||electrocardiography:1||endocardium:1||endothelial function:1||epicardial adipose tissue:1||epicardial fat:1||epinephrine:1||ethnic groups:1||everolimuseluting stents:1||exercise capacity:1||exfoliative dermatitis:1||extracellular fluid:1||ezetimibe:1||fibroelastosis:1||followup:1||global health:1||hand grip strength:1||handgrip:1||healthy volunteers:1||heart atria/pathology/ultrasonography:1||heart failure:1||hypercholesterolemia:1||hyperlipidemias/prevention & control:1||hyperuricaemia:1||hyperuricemia:1||index of microvascular resistance:1||inflammation:1||inflammatory:1||insulin resistance:1||intracoronary acetylcholine provocation test:1||large artery stiffness:1||left:1||left atrial function:1||left ventricular:1||left ventricular hypertrophy:1||left ventricular mass:1||lipids:1||lipoproteins, LDL/blood/chemistry:1||long lesion: percutaneous coronary intervention:1||lowdensity lipoprotein cholesterol:1||major adverse cardiac events:1||meloxicam:1||metabolic syndrome:1||mortality:1||multidetector computed tomography:1||multivessel:1||multivessel coronary artery spasm:1||myocardial ischemia:1||newonset diabetes mellitus:1||nitrate:1||nonSTsegmentelevation myocardial infarction:1||noncontact mapping:1||nonionic contrast medium (iodixanol):1||nonselective ssblockers:1||nonsteroidal antiinflammatory drugs:1||odds ratio:1||older people:1||outcome:1||particle size:1||percutaneous coronary intervention/adverse effects/mortality:1||percutaneous transluminal angioplasty:1||peripartum period:1||peripheral arterial disease:1||peripheral artery disease:1||peripheral transluminal angioplasty:1||phoshorylcholine:1||pitavastatin:1||positive predictive value:1||prehospital delay:1||prediabetes:1||predictive value of tests:1||pregnancy:1||prehypertension:1||preoperative care/methods:1||primary prevention:1||public reporting:1||pulse pressure:1||pulse wave analysis:1||quality of care:1||rational pharmacotherapy:1||recanalization:1||recovery of function:1||recurrence:1||registries:1||remodeling:1||reninangiotensin system:1||reperfusion:1||retrospective studies:1||risk assessment:1||risk factor:1||safety:1||sarcopenia:1||selective ss 1blockers:1||sex differences:1||sex discrepancies:1||sirolimuseluting stent:1||skeletal muscle index:1||sleep:1||sleep deprivation:1||small:1||smartphone app:1||smoker's paradox:1||specificity:1||stable angina:1||statin responsiveness:1||stent boost:1||stent fracture:1||stents:1||subacute stent thrombosis:1||superior mesenteric artery aneurysms:1||threedimensional:1||threedimensional multidetector CT:1||thrombolysis in myocardial infarction flow:1||thrombosis:1||tissue Doppler:1||tissue Doppler imaging:1||tomography, Xray computed/methods:1||type 2 diabetes:1||unstable plaque:1||validation studies:1||ventricular function:1||visceral artery aneurysms:1||young patients:1||zotarolimus:1||zotarolimuseluting stents:1||맥파속도:1||중심 동맥압:1||파형증가 지수:1||한국인의 관동맥질환에 띠른 혈중 지질 및 위험인자의 비교연구:1||(V)over doto(2max):1||혈관경직도:1||18FFDGPET/CT:1||24hour Holter study:1||6minute walk test:1||ADAM10:1||ADP:1||Ablation time:1||Access site:1||Acetylcholine dose:1||Achinduced coronary vasospasm:1||Ach: acetylcholine:1||Acute nonSTsegment elevation myocardial infarction:1||Alcohol:1||Amlodipine:1||Amygdalar activity:1||Aneurysm:1||Angina:1||Angina pectoris:1||Angina pectoris, variant:1||Angiography:1||Angiotensin II receptor blocker:1||Angiotensin II type 1 receptor blocker:1||Antilipemic agents/therapeutic use:1||Antiplatelet therapy:1||Anysis:1||Anysis200 analyzer:1||Aorta:1||Aortic calcification:1||Aortic stiffness:1||Arterial inflammation:1||Arterial stiffness:1||Asian:1||Atherosclerosis:1||Atopic dermatitis:1||Atrial fibrillation/physiopathology:1||Atrial mass:1||Atrial remodeling:1||Atrial septal aneurysm:1||Atrial septum:1||Augmentation index:1||Btype natriuretic peptide:1||BMS:1||BVS:1||Balloon:1||Baremetal stent:1||BioLinx:1||Bioelectrical impedance analysis:1||Blood glucose:1||Blood pressure:1||Buerger's disease:1||CABG:1||CAS:1||CTO:1||CV events:1||Cardiac CT:1||Cardiopulmonary coupling analysis:1||Cardiorespiratory Fitness:1||Cardiorespiratory fitness:1||Cardiovascular Disease:1||Cardiovascular disease:1||Cardiovascular outcome:1||Central blood pressure:1||Chest CT:1||Chronic kidney disease:1||Chronic outward force:1||Cigarette smoking:1||Cilostazol:1||Cilotax (TM) stent:1||Circumflex coronary artery:1||Clinical followup:1||Clinical implications:1||Clinical outcome:1||Clopidogrel:1||Coagulation:1||Complex fractionated atrial electrograms:1||Complications:1||Computed tomography:1||Congenital:1||Coronary:1||Coronary angiography:1||Coronary anomaly:1||Coronary artery stenosis:1||Coronary calcification:1||Coronary circulation:1||Coronary disease:1||Coronary occlusion/therapy:1||Coronary rupture:1||Coronary stenosis:1||Coronary vessels:1||Critical limb ischemia:1||Cryptogenic stroke:1||DXR (TM) stent:1||

STATISTICS: Total View :13,966,270; Today View :14,223

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE